NDC 84892-275-02 - YUVEZZI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 84892-275
- Requested NDC
- 84892-275-02
- Package NDCs from labels
- 84892-275-01, 84892-275-02, 84892-275-30, 84892-275-99
- Manufacturer
- Visus Therapeutics, Inc.
- Effective date
- 2026-05-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| YUVEZZI - Visus Therapeutics, Inc. | Visus Therapeutics, Inc. | 2026-05-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84892-275-01 | YUVEZZI | 0.16 mL in 1 VIAL, SINGLE-DOSE | SOLUTION/ DROPS | 0.16 | 4 | |
| 84892-275-02 | YUVEZZI | 5 in 1 POUCH | SOLUTION/ DROPS | 5 | 4 | |
| 84892-275-30 | YUVEZZI | 6 in 1 CARTON | SOLUTION/ DROPS | 6 | 4 | |
| 84892-275-99 | YUVEZZI | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 84892-275-02 | EA - Each | 84892-275 | 1b3cc6f2-de1c-4271-95ad-14d1715a888b | 1 | 2026-03-17 |
| 84892-275-30 | EA - Each | 84892-275 | c3d300c3-702c-45ab-9251-9d3fb37f77ea | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ENCON EYEWASH | EYEWASH | Encon Safety Products, Inc. | 485c691e-f6a8-4836-e063-6294a90a16fc | 2026-10-29 | Warnings | 059QF0KO0R |
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2026-10-26 | Warnings, Adverse reactions | 593YOG76RN |
| MB CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | 2efeb281-b84b-4750-e063-6394a90a27ee | 2026-10-26 | Warnings, Adverse reactions | 593YOG76RN |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| SODIUM PHOSPHATES | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Amneal Pharmaceuticals Private Limited | 62db5220-13ec-4cb9-b705-8a908a174dba | 2026-10-16 | Warnings, Adverse reactions | 70WT22SF4B 593YOG76RN |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| Brimonidine tartrate and Timolol maleate | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | NorthStar RxLLC | be282a72-0797-449d-ae07-fb8d4bdcc0a5 | 2026-09-28 | Warnings, Adverse reactions | 4S9CL2DY2H |
| Brimonidine Tartrate | BRIMONIDINE TARTRATE | Apotex Corp. | 64b21e68-610c-5194-ccb2-9d9f6ff8cda9 | 2026-09-28 | Warnings, Adverse reactions | 4S9CL2DY2H |
| Rugby Eye Wash | WATER, PURIFIED | Rugby Laboratories | 1fee974b-4c29-4965-bd3d-da5e219eb13a | 2026-09-24 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | B. Braun Medical Inc. | f4284eb6-e553-46d4-90d8-efc80a90a480 | 2026-09-18 | Warnings, Adverse reactions | 059QF0KO0R |
| FlyLeaf RINGWORM TREATMENT | MICONAZOLE NITRATE 2% | Guangzhou Huixue Biotechnology Co., Ltd. | 5b597a3b-b5ff-2246-e063-6394a90a1046 | 2026-09-13 | Warnings | 059QF0KO0R |
| Brimonidine Tartrate | BRIMONIDINE TARTRATE | Apotex Corp. | e08a915a-77ca-4d16-d760-11b05848418d | 2026-09-09 | Warnings, Adverse reactions | 4S9CL2DY2H |
| Brimonidine Tartrate Ophthalmic Solution | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | Lifestar Pharma LLC | f6666d85-f810-4869-993d-e8ae35b4517f | 2026-09-03 | Warnings, Adverse reactions | 4S9CL2DY2H |
| BMNP Nat Phos | NATRUM PHOSPHORICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a581272-69f3-fd52-e063-6394a90a1de4 | 2026-08-31 | Warnings | 70WT22SF4B |
| KUGIG ALOE FOAMING INTIMATE WASH | INTIMATE CLEANSING FOAM | Hong Kong KangXing Centennial Management Limited | 59f4d398-1186-a168-e063-6294a90ab44b | 2026-08-26 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | 3NXW29V3WO |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.